SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Stabilisation Notice

7 Sep 2017 09:34

RNS Number : 0984Q
J.P. Morgan Securities PLC.
07 September 2017
Β 

07th September 2017

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Nationwide Building Society ("Nationwide")

Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/2016/1052 under the Market Abuse Regulation (EU/596/2014).

The securities:

Issuer:

Nationwide Building Society ("Nationwide")

Guarantor (if any):

N/A

Aggregate nominal amount:

Β£ TBC Core Capital Deferred Shares

Β 

Description:

Tap of Core Capital Deferred Shares ("CCDS") 10.25% Perp

Β 

Offer price:

TBC

Other offer terms:

Immediately fungible on ISIN- GB00BBQ33664

Stabilisation:

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

Merrill Lynch International (Stabilisation Manager)

Barclays Bank PLC (Stabilisation Manager)

Citigroup Global Capital Markets Limited (Stabilisation Manager)

UBS Limited (Stabilisation Manager)

Stabilisation period expected to start on:

7h September 2017

Stabilisation period expected to end no later than:

8th October 2017

Existence, maximum size and conditions of use of over‑allotment facility:

In connection with its stabilising activities Nationwide has granted J.P. Morgan, on behalf of the underwriters, an over-allotment option, exercisable, in whole or in part, at any time during the period commencing after the announcement of the Offer Price and ending on the business day falling immediately prior to the publication of the Prospectus, which if exercised, will require Nationwide to issue up to 15 per cent. of the aggregate number of CCDS available in the Offer (before any exercise of the Over-allotment Option) at the Offer Price to cover short positions arising from such over-allotments (if any) and/or sales of CCDS effected by it during the stabilising period.

J.P. Morgan has agreed with Nationwide that any over-allotment of CCDS by it or any of its agents will be up to a maximum of 15 per cent. of the total number of CCDS comprised in the Offer (before any exercise of the Over-allotment Option).

Stabilisation trading venue:

Over the counter, TBC

Β 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities or effect other transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the day falling 30 calender days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
STAEAPNXEDFXEEF
Date   Source Headline
18th Aug 20228:44 amRNSPublication of Final Terms
17th Aug 20229:04 amRNSPublication of Final Terms
10th Aug 202211:08 amRNSPost Stab Notice - Nationwide Building Society
5th Aug 20222:47 pmRNSPublication of Final Terms
5th Aug 20222:46 pmRNSPublication of Final Terms
26th Jul 20222:53 pmRNSPublication of Final Terms
20th Jul 20223:22 pmRNSPublication of Final Terms
20th Jul 20223:22 pmRNSPublication of Final Terms
14th Jul 20223:43 pmRNSResult of AGM
12th Jul 20229:29 amRNSPre Stabilisation Notice - Nationwide Building Soc
24th Jun 202210:45 amRNSPublication of a Prospectus
10th Jun 20227:30 amRNSResolvability Assessment Framework
9th Jun 20224:56 pmRNSFurther re Tender Offer
25th May 20223:01 pmRNSTender Offer
20th May 202212:44 pmRNSPublication of Supplemental Prospectus
20th May 20227:00 amRNSAnnual Financial Report
16th May 20222:21 pmRNSPublication of Final Terms
26th Apr 20226:00 pmRNSPublication of Final Terms
5th Apr 20224:10 pmRNSRedemption of Notes
1st Apr 20229:00 amRNSDirectorate Change
1st Mar 20229:00 amRNSBoard Changes
25th Feb 20223:19 pmRNSPublication of a Prospectus
15th Feb 20229:23 amRNSPublication of Final Terms
15th Feb 20229:23 amRNSPublication of Final Terms
28th Jan 20228:00 amRNSBoard Changes
14th Dec 20217:00 amRNSResponse to Results of BoE Stress Test 2021
10th Dec 20211:51 pmRNSPublication of Base Prospectus
10th Dec 20211:41 pmRNSPublication of Base Prospectus
3rd Dec 20218:00 amRNSLeadership Succession
19th Nov 202111:13 amRNSPublication of Suppl.Prospcts
19th Nov 20217:00 amRNSHalf-year Report
29th Oct 20213:34 pmRNSPublication of a Prospectus
19th Oct 20217:00 amRNSPermanent Interest Bearing Shares Call Notice
11th Oct 20214:23 pmRNSPublication of Final Terms
23rd Sep 20219:00 amRNSLeadership Succession
10th Sep 20215:36 pmRNSPublication of Final Terms
22nd Jul 20212:49 pmRNSResults of AGM and Board changes
7th Jul 20211:57 pmRNSResult of Meeting
29th Jun 202112:15 pmRNSPublication of a Base Prospectus
3rd Jun 202111:00 amRNSCirc re. Notice of Meeting
3rd Jun 202110:59 amRNSTender Offer and Consent Solicitation
24th May 20211:53 pmRNSPublication of Suppl.Prospcts
21st May 20217:00 amRNSAnnual Financial Report
5th May 20212:06 pmRNSPublication of Final Terms
1st Apr 20219:46 amRNSPublication of Suppl.Prospcts
1st Mar 20216:05 pmRNSPublication of Final Terms
1st Mar 20211:00 pmRNSAppointment of Non-Executive Director
12th Feb 20216:03 pmRNSPublication of a Prospectus
22nd Jan 202110:39 amRNSPublication of Final Terms
7th Jan 202112:32 pmRNSPublication of a Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.